MedTrace Logo

Myocardial Perfusion Imaging in Liver Transplantation Candidates

NCT03864497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2019-06-19

No results posted yet for this study

Summary

The optimal screening strategy for assessment of coronary artery disease in patients with end-stage liver disease (ESLD) is unclear. Although consensus based guidelines support noninvasive stress testing prior to orthotopic liver transplantation (OLT), no prospective studies are available to inform the clinician on perioperative risk stratification. This observational cohort study was designed to determine the prognostic utility of single photon emission computed tomography (SPECT) imaging in OLT candidates.

Conditions

  • Myocardial Perfusion Imaging
  • Liver Failure

Interventions

PROCEDURE

Myocardial perfusion imaging

Sponsors & Collaborators

  • University Hospital Birmingham NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Richard P Steeds, MD · University Hospital Birmingham NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2019-06-30
Completion
2019-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03864497 on ClinicalTrials.gov